o2h discovery
Simon Reidar Stockwell is an experienced scientist and team leader currently serving at o2h discovery since June 2022, following a tenure at Fortis Pharma Consulting Ltd, where Simon held roles as Medical Writer and Associate Medical Writer. Prior experience includes significant positions at the University of Cambridge as Research Project Manager, where Simon contributed to impactful drug discovery projects, and at UCL, specializing in cancer cell signaling and target validation. Simon also worked as a Postdoctoral Research Fellow at The Institute of Cancer Research, focusing on drug discovery and screening methodologies. Simon holds a PhD in Molecular Biology from The Institute of Cancer Research and a BS in Biochemistry from The University of Manchester.
This person is not in any offices
o2h discovery
Founded in 2005, o2h discovery is a Contract Research Organisation which has an integrated drug discovery platform operating from our state-of-the-art research centre in India and The Mill SciTech Park, Cambridge, UK. We have the in-house capability to execute hit-lead-optimization programs leading into patent and IND filing from our state-of-the-art biotechnology incubator with expertise in discovery chemistry, biology, pharmacology, and the ongoing project management of pre-clinical development. o2h discovery has developed and launched its proprietary application Chemistry in the Cloud™ (CITC), the world’s first app to revolutionize the project management of external drug discovery programs. The app enables communication between various scientific stakeholders essential to successful project advancement – leading to faster decision making. The DNA of o2h discovery is centered around the nurturing of its people, values, and culture. It reflects in the way we work with each other, as well as our collaborators and partners. For more information about o2h group, please visit www.o2h.com and to know more about our chemistry & biology services, please see – https://o2hdiscovery.co